T/CNMIA 0039-2023 Active Group standards

T/CNMIA 0039-2023 Assessment of the ability of social-run molecular pathology laboratories to provide medical quality services

Publish Date: 2023-05-26 Implement Date: 2023-05-29 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Download

Basic Information

Standard Code: T/CNMIA 0039-2023

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Laboratory medicine

Publish Date: 2023-05-26

Implement Date: 2023-05-29

Pages: 29 pages

Scope

Scope: Social-run molecular pathology laboratories; Main technical content: Social-run molecular pathology laboratories are an important component of China's medical system, undertaking important clinical molecular pathology detection work. However, due to the lack of a unified industry access, evaluation index system, and supervision system, molecular pathology laboratories vary greatly in terms of strict adherence to industry norms, basic laboratory qualifications, standardized laboratory construction, quality control, detection capabilities, and detection levels, which is extremely detrimental to the improvement of clinical medical level and quality assurance, and affects the healthy development of the entire industry. In order to improve their service capabilities and service quality, enable detection results to reach a level that can be mutually recognized among peers in the same industry, and reduce resource waste, it is necessary to establish a set of scientific, objective, and fair grading evaluation standards for molecular pathology laboratories. The establishment of this standard will play an important role in promoting the healthy development of the entire industry.